83_FR_46124 83 FR 45948 - National Institute on Drug Abuse Amended; Notice of Meeting

83 FR 45948 - National Institute on Drug Abuse Amended; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 176 (September 11, 2018)

Page Range45948-45948
FR Document2018-19608

Federal Register, Volume 83 Issue 176 (Tuesday, September 11, 2018) 
[Federal Register Volume 83, Number 176 (Tuesday, September 11, 2018)]
[Notices]
[Page 45948]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-19608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse Amended; Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute on Drug Abuse Special Emphasis Panel, September 25, 2018, 
10:00 a.m. to September 25, 2018, 12:00 p.m., National Institutes of 
Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 
20852 which was published in the Federal Register on August 15, 2018, 
83 159 FR 2018-17674.
    The meeting date was changed to October 9, 2018. The meeting time 
did not change. The meeting is closed to the public.

    Dated: September 5, 2018.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-19608 Filed 9-10-18; 8:45 am]
 BILLING CODE 4140-01-P

45948 Federal Register / Vol. 83, No. 176 / Tuesday, September 11, 2018 / Notices In response to this Notice, the public Closed: 1:00 p.m. to 5:00 p.m. Emphasis Panel; NIAID Clinical Trial may file comments or objections. Agenda: To review and evaluate grant Implementation Cooperative Agreement (U01 Comments and objections, other than applications. Clinical Trial Required) and NIAID SBIR Place: NIH, National Eye Institute, 6700B Phase II Clinical Trial Implementation those in the form of a license Rockledge Drive, First Floor Conference Cooperative Agreement (U44 Clinical Trial application, will not be treated Rooms, Bethesda, MD 20817. confidentially, and may be made Required). Contact Person: Paul A. Sheehy, Ph.D., publicly available. Director, Division of Extramural Affairs, Date: October 10, 2018. License applications submitted in National Eye Institute, National Institutes of Time: 11:00 a.m. to 3:00 p.m. response to this Notice will be Health, 5635 Fishers Lane, Suite 12300, Agenda: To review and evaluate grant presumed to contain business Bethesda, MD 20892, 301–451–2020, ps32h@ applications. confidential information and any release nih.gov. Place: National Institutes of Health, 5601 of information in these license Information is also available on the Fishers Lane, Rockville, MD 20892 applications will be made only as Institute’s/Center’s home page: (Telephone Conference Call). required and upon a request under the www.nei.nih.gov, where an agenda and any Contact Person: Brenda Lange-Gustafson, additional information for the meeting will Ph.D., Scientific Review Officer, NIAID/NIH/ Freedom of Information Act, 5 U.S.C. be posted when available. 552. DHHS, Scientific Review Program,5601 (Catalogue of Federal Domestic Assistance Fishers Lane, Room 3G13, Rockville, MD Dated: August 31, 2018. Program Nos. 93.867, Vision Research, 20852, 240–669–5047, bgustafson@ Richard U. Rodriguez, National Institutes of Health, HHS) niaid.nih.gov. Associate Director, Technology Transfer Dated: September 5, 2018. (Catalogue of Federal Domestic Assistance Center, National Cancer Institute. Natasha M. Copeland, Program Nos. 93.855, Allergy, Immunology, [FR Doc. 2018–19604 Filed 9–10–18; 8:45 am] Program Analyst, Office of Federal Advisory and Transplantation Research; 93.856, BILLING CODE 4140–01–P Committee Policy. Microbiology and Infectious Diseases [FR Doc. 2018–19606 Filed 9–10–18; 8:45 am] Research, National Institutes of Health, HHS) BILLING CODE 4140–01–P Dated: September 5, 2018. DEPARTMENT OF HEALTH AND HUMAN SERVICES Natasha M. Copeland, DEPARTMENT OF HEALTH AND Program Analyst, Office of Federal Advisory National Institutes of Health Committee Policy. HUMAN SERVICES National Eye Institute; Notice of [FR Doc. 2018–19607 Filed 9–10–18; 8:45 am] Meeting National Institutes of Health BILLING CODE 4140–01–P Pursuant to section 10(d) of the National Institute of Allergy and Federal Advisory Committee Act, as Infectious Diseases; Notice of Closed DEPARTMENT OF HEALTH AND amended, notice is hereby given of a Meetings HUMAN SERVICES meeting of the National Advisory Eye Pursuant to section 10(d) of the Council. Federal Advisory Committee Act, as National Institutes of Health The meeting will be open to the amended, notice is hereby given of the public as indicated below, with National Institute on Drug Abuse following meetings. attendance limited to space available. The meetings will be closed to the Amended; Notice of Meeting Individuals who plan to attend and public in accordance with the need special assistance, such as sign provisions set forth in sections Notice is hereby given of a change in language interpretation or other 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., the meeting of the National Institute on reasonable accommodations, should as amended. The grant applications and Drug Abuse Special Emphasis Panel, notify the Contact Person listed below the discussions could disclose September 25, 2018, 10:00 a.m. to in advance of the meeting. confidential trade secrets or commercial September 25, 2018, 12:00 p.m., The meeting will be closed to the National Institutes of Health, property such as patentable material, public in accordance with the Neuroscience Center, 6001 Executive and personal information concerning provisions set forth in sections Boulevard, Rockville, MD 20852 which individuals associated with the grant 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which was published in the Federal Register as amended. The grant applications and would constitute a clearly unwarranted on August 15, 2018, 83 159 FR 2018– the discussions could disclose invasion of personal privacy. 17674. confidential trade secrets or commercial property such as patentable material, Name of Committee: National Institute of The meeting date was changed to and personal information concerning Allergy and Infectious Diseases Special October 9, 2018. The meeting time did Emphasis Panel; NIAID Peer Review Meeting. individuals associated with the grant not change. The meeting is closed to the Date: October 10, 2018. applications, the disclosure of which Time: 10:30 a.m. to 6:00 p.m. public. would constitute a clearly unwarranted Agenda: To review and evaluate contract Dated: September 5, 2018. invasion of personal privacy. proposals. Natasha M. Copeland, Name of Committee: National Advisory Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 Program Analyst, Office of Federal Advisory Eye Council. Date: October 12, 2018. (Telephone Conference Call). Committee Policy. daltland on DSKBBV9HB2PROD with NOTICES Open: 8:30 a.m. to 12:00 p.m. Contact Person: Chelsea D. Boyd, Ph.D., [FR Doc. 2018–19608 Filed 9–10–18; 8:45 am] Agenda: Following opening remarks by the Scientific Review Officer, Scientific Review BILLING CODE 4140–01–P Director, NEI, there will be presentations by Program, DEA/NIAID/NIH/DHHS, 5601 the staff of the Institute and discussions Fishers Lane, MSC–9823, Rockville, MD concerning Institute programs. 20852–9834, 240–669–2081, chelsea.boyd@ Place: NIH, National Eye Institute, 6700B nih.gov. Rockledge Drive, First Floor Conference Name of Committee: National Institute of Rooms, Bethesda, MD 20817. Allergy and Infectious Diseases Special VerDate Sep<11>2014 18:49 Sep 10, 2018 Jkt 244001 PO 00000 Frm 00074 Fmt 4703 Sfmt 9990 E:\FR\FM\11SEN1.SGM 11SEN1


Document Created: 2018-09-11 01:03:27
Document Modified: 2018-09-11 01:03:27
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation83 FR 45948 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR